NADMED AWARD

$30,000 for New Discoveries in Metabolomics

Redox metabolites have long been virtually impossible to measure — until now! With its novel technology, NADMED has made it possible to accurately quantify all four forms of NAD as well as both reduced and oxidized glutathione. The results surpass even the traditional gold standard, mass spectrometry. | Nadmed Ltd | The standard of NAD measuring
The NADMED Award 2025 calls on innovators in science and medicine to push the frontiers of metabolomics! Apply now for $30,000 in technology and collaboration reviewed by a world-class scientific jury. This global competition empowers researchers to explore redox biology using NADMED’s cutting-edge technology.

Redox metabolites have long been virtually impossible to measure — until now! With its novel technology, NADMED has made it possible to accurately quantify all four forms of NAD as well as both reduced and oxidized glutathione. The results surpass even the traditional gold standard, mass spectrometry.

NADMED now invites academic research laboratories, pharmaceutical companies, clinical laboratories, and other innovative organizations to join in advancing scientific knowledge and fostering collaboration in the study of key redox metabolites.

The NADMED Award will be granted to the most promising research projects that make a significant contribution to the scientific community and/or advances drug discovery. Winning projects will receive NADMED metabolomics kits, expert consultation, and in-house measurement services valued at $30,000.

Researchers are encouraged to submit applications describing how they would apply NADMED metabolomics kits to explore biological systems. Whether your focus is on blood, tissues, or cells, NADMED enables precise and reliable measurement of six critical metabolites: NAD⁺, NADH, NADP⁺, NADPH, reduced glutathione (GSH), and oxidized glutathione (GSSG).